Home / Intelligence / Case Studies / Early Payer Guidance Across Four Inflammatory Disease Areas
Trinity completed an early payer guidance engagement, conducting comprehensive secondary research across four inflammatory disease areas.
Geographic Scope: 
Client Situation
The client wanted to gain an in-depth understanding of four inflammatory disease areas to inform early stage decision-making.
Trinity’s Solution
Trinity conducted comprehensive secondary research in the following areas:
- Disease background including diagnosis, prognosis, epidemiology and unmet needs
- Current and future paradigm including lines of therapies and standard of care
- Pipeline analysis including key therapies in development and future treatment gamechangers
- Pricing and access landscape including pricing analysis, health technology assessment (HTA) outcomes and access status
Deliverables
Four disease-specific early payer guidance reports powered by comprehensive secondary research efforts into disease background, current and future treatment paradigm, pipeline analysis and pricing and access landscape.
Project Outcomes & Impact
Trinity’s comprehensive secondary research and landscape analyses helped the client to make early-stage decisions across therapeutic areas of interest from a future business development perspective.
Related Intelligence
Webinars
Innovation in Value Strategy: Disrupting the Value Communication Landscape
September 25, 2024 | 12:00 – 12:45 PM ET
Two additional sessions will be offered: September 26 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai September 26 – 15:00 – 15:45 CET – Europe/Berlin Working at the cutting edge of pricing and market access for innovative therapies launched over the last decade, Trinity Life Sciences has seen new diseases, technologies and decision drivers emerge. These have […]
Sign Up Now
White Papers
Solving a Pervasive Challenge: Breaking Down Silos in Life Sciences
Experts at Trinity Life Sciences interact with the inner workings of pharma from many perspectives as they engage with teams across life sciences organizations. A common observation is that teams are working in silos: often unaware of what other teams are doing, sometimes pulling in different directions and frequently experiencing frustrations. Internally, siloed working can […]
Read More
Webinars
Policy Change Through Another Lens: Impact on Health Plans and Implications for Biopharma
Available On Demand
The second webinar in our “Next Era in U.S. Healthcare Policy & Access” series looks at the evolving healthcare policy landscape from a different perspective. Join us as we explore how U.S. policy changes are impacting health plans, how health plan decision-making needs to adapt, and what this means for biopharma companies. The webinar will […]
Watch Now